| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5502745 | Journal of the Neurological Sciences | 2017 | 25 Pages |
Abstract
Our study showed that tacrolimus would be an effective immunosuppressant as an initial therapeutic agent in patients with MG; in addition, it showed tolerable safety profiles during the 12-month follow-up evaluation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Suk-Won Ahn, In Soo Joo, Byung-Jo Kim, Jung-Joon Sung, Sa-Yoon Kang, Jeeyoung Oh, Yang-Ki Minn, Bum Chun Suh, Sun-Young Oh, Yoon-Ho Hong, Tai-Seung Nam, Jung Im Seok, Young-Eun Park, Ha Young Shin, Eun Bin Cho, Je-Young Shin, Hung Youl Seok,